JP2006257074A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006257074A5 JP2006257074A5 JP2006034041A JP2006034041A JP2006257074A5 JP 2006257074 A5 JP2006257074 A5 JP 2006257074A5 JP 2006034041 A JP2006034041 A JP 2006034041A JP 2006034041 A JP2006034041 A JP 2006034041A JP 2006257074 A5 JP2006257074 A5 JP 2006257074A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- cationic peptide
- physiologically active
- active protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 125000002091 cationic group Chemical group 0.000 claims 8
- 102000004169 proteins and genes Human genes 0.000 claims 8
- 108090000623 proteins and genes Proteins 0.000 claims 8
- ODKSFYDXXFIFQN-SCSAIBSYSA-N OC(=O)[C@H](N)CCCNC(N)=N Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 claims 2
- 230000000975 bioactive Effects 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- 239000004475 Arginine Substances 0.000 claims 1
- 210000004369 Blood Anatomy 0.000 claims 1
- 102400000113 Calcitonin Human genes 0.000 claims 1
- 108060001064 Calcitonin Proteins 0.000 claims 1
- 229960004015 Calcitonin Drugs 0.000 claims 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims 1
- 102000018997 Growth Hormone Human genes 0.000 claims 1
- 108010051696 Growth Hormone Proteins 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- 229940047124 Interferons Drugs 0.000 claims 1
- 102000014150 Interferons Human genes 0.000 claims 1
- 108010050904 Interferons Proteins 0.000 claims 1
- 102000015696 Interleukins Human genes 0.000 claims 1
- 229940047122 Interleukins Drugs 0.000 claims 1
- 108010063738 Interleukins Proteins 0.000 claims 1
- 210000000936 Intestines Anatomy 0.000 claims 1
- 108060006601 PRM1 Proteins 0.000 claims 1
- 102000003982 Parathyroid hormone Human genes 0.000 claims 1
- 108090000445 Parathyroid hormone Proteins 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000000122 growth hormone Substances 0.000 claims 1
- 239000000199 parathyroid hormone Substances 0.000 claims 1
- 229960001319 parathyroid hormone Drugs 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 229940048914 protamine Drugs 0.000 claims 1
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006034041A JP5103748B2 (en) | 2005-02-16 | 2006-02-10 | Pharmaceutical composition |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005038850 | 2005-02-16 | ||
| JP2005038850 | 2005-02-16 | ||
| JP2006034041A JP5103748B2 (en) | 2005-02-16 | 2006-02-10 | Pharmaceutical composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006257074A JP2006257074A (en) | 2006-09-28 |
| JP2006257074A5 true JP2006257074A5 (en) | 2009-02-26 |
| JP5103748B2 JP5103748B2 (en) | 2012-12-19 |
Family
ID=37096715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006034041A Active JP5103748B2 (en) | 2005-02-16 | 2006-02-10 | Pharmaceutical composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5103748B2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101959532B (en) | 2008-02-28 | 2013-02-27 | 东丽株式会社 | Pharmaceutical composition for transnasal administration |
| WO2011005540A1 (en) | 2009-06-22 | 2011-01-13 | Burnham Institute For Medical Research | Methods and compositions using peptides and proteins with c-terminal elements |
| HUP0900482A2 (en) * | 2009-08-03 | 2011-03-28 | Cera Med Kft | Pharmaceutical formulation for oral administration |
| WO2017183559A1 (en) * | 2016-04-19 | 2017-10-26 | 学校法人神戸学院 | Transmucosal absorption promoter for drug |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61115030A (en) * | 1984-11-07 | 1986-06-02 | Lion Corp | Remedy for osteopathy |
| JP3770666B2 (en) * | 1996-09-20 | 2006-04-26 | 株式会社ティ・ティ・エス技術研究所 | Composition for transmucosal absorption preparation |
| SK262001A3 (en) * | 1998-07-08 | 2001-09-11 | Kirin Amgen Inc | Powdery preparation for mucosal administration containing polymeric medicine |
| JP2000281589A (en) * | 1999-03-26 | 2000-10-10 | T T S Gijutsu Kenkyusho:Kk | Transmucosal absorption adjuvant |
| AU2002354951A1 (en) * | 2001-07-19 | 2003-03-03 | Dmi Biosciences, Inc. | Use of copper chelators to inhibit the inactivation of protein c |
-
2006
- 2006-02-10 JP JP2006034041A patent/JP5103748B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010515686A5 (en) | ||
| JP2009292810A5 (en) | ||
| JP2005516885A5 (en) | ||
| JP5683951B2 (en) | Compositions for long acting peptide analogs | |
| JP2013515055A5 (en) | ||
| HRP20140616T1 (en) | Oxyntomodulin peptide analogue | |
| IL199263A (en) | Glucagon peptide with improved solubility, a pharmaceutical composition comprising same and uses thereof for the preparation of medicaments | |
| JP2007001987A5 (en) | ||
| RU2020136305A (en) | GIP DERIVATIVES AND THEIR APPLICATIONS | |
| RU2014103288A (en) | RELAXIN FUSED POLYPEPTIDES AND THEIR APPLICATION | |
| JP2005519041A5 (en) | ||
| JP2009017881A5 (en) | ||
| JP2005509609A5 (en) | ||
| EP2390265A3 (en) | Insulinotropic peptide derivative wherein its N-terminal amino acid is modified | |
| EP2341142A3 (en) | HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising same | |
| RU2009146883A (en) | STABLE NON-AQUE PHARMACEUTICAL COMPOSITIONS | |
| HRP20050683A2 (en) | Polyethylene glycol linked glp-1 compounds | |
| HRP20171048T1 (en) | Novel angiotensin type 2 (at2) receptor agonists and uses thereof | |
| JP2006257074A5 (en) | ||
| RU2014127270A (en) | ANALOGUE OF HUMAN INSULIN AND ITS Acylated Derivative | |
| JP2014532722A5 (en) | ||
| RU2016123180A (en) | CALCITONIN MIMETICS FOR THE TREATMENT OF DISEASES AND DISORDERS | |
| RU2014122171A (en) | PEPTIDE ANALOGUES FOR TREATMENT OF DISEASES AND DISORDERS | |
| JP2006506942A5 (en) | ||
| JP2014516049A5 (en) |